Terpenoid ID | TKC112796 | |
Cell line | 0 | |
Protein target | 1 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 7 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC112796 | SH-SY5Y | SH-Sy5y; SHSY5Y; SHSY-5Y; SK-SH-SY5Y; SY5Y; SH-SY5Y Parental | 16.0 | % | Activity | C3270 | Orphanet_635 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC112796 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 49970 | nM | IC50 |
TKC112796 | P17706 | Tyrosine-protein phosphatase non-receptor type 2 | PTPN2 | <50 | % | Inhibition |
TKC112796 | P10586 | Receptor-type tyrosine-protein phosphatase F | PTPRF | <50 | % | Inhibition |
TKC112796 | P29350 | Tyrosine-protein phosphatase non-receptor type 6 | PTPN6 | <50 | % | Inhibition |
TKC112796 | Q06124 | Tyrosine-protein phosphatase non-receptor type 11 | PTPN11 | <50 | % | Inhibition |
TKC112796 | P30305 | M-phase inducer phosphatase 2 | CDC25B | <50 | % | Inhibition |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
P18031 | PTN1_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 | PTN1_HUMAN | Acute diabete complication [ICD-11: 5A2Y] |
P18031 | PTN1_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 | PTN1_HUMAN | Obesity [ICD-11: 5B80-5B81] |
P18031 | PTN1_HUMAN | Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 | PTN1_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 | PTN1_HUMAN | Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 | PTN1_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
P17706 | PTN2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q06124 | PTN11_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P30305 | MPIP2_HUMAN | Lung cancer [ICD-11: 2C25] |
P30305 | MPIP2_HUMAN | Nasopharyngeal cancer [ICD-11: 2B6B] |
P30305 | MPIP2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |